The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jodo, S.
Right arrow Articles by Ju, S.-T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jodo, S.
Right arrow Articles by Ju, S.-T.
The Journal of Immunology, 2005, 174: 4470-4474.
Copyright © 2005 by The American Association of Immunologists


CUTTING EDGE

Cutting Edge: Fas Ligand (CD178) Cytoplasmic Tail Is a Positive Regulator of Fas Ligand-Mediated Cytotoxicity1

Satoshi Jodo2,*, Vyankatesh J. Pidiyar2,{dagger}, Sheng Xiao{dagger}, Akira Furusaki*, Rahul Sharma{dagger}, Takao Koike* and Shyr-Te Ju3,{dagger}

* Department of Medicine II, Hokkaido University Graduate School of Medicine, Sapporo, Japan; and {dagger} Division of Rheumatology and Immunology, Department of Internal Medicine, University of Virginia, Charlottesville, VA 22908

The cytotoxic function of CD178 (Fas ligand (FasL)) is critical to the maintenance of peripheral tolerance and immune-mediated tissue pathology. The active site of FasL resides at the FasL extracellular region (FasLExt) and it functions through binding/cross-linking Fas receptor on target cells. In this study, we report that FasLExt-mediated cytotoxicity is regulated by the FasL cytoplasmic tail (FasLCyt). Deleting the N-terminal 2–70 aa ({Delta}70) or N-terminal 2–33 aa ({Delta}33) reduced the cytotoxic strength as much as 30- to 100-fold. By contrast, change in the cytotoxic strength was not observed with FasL deleted of the proline-rich domains (45–74 aa, {Delta}PRD) in the FasLCyt. Our study identifies a novel function of FasLCyt and demonstrates that FasL2–33, a sequence unique to FasL, is critically required for the optimal expression of FasLExt-mediated cytotoxicity.




This article has been cited by other articles:


Home page
J. Immunol.Home page
L. Zheng, R. Sharma, F. Gaskin, S. M. Fu, and S.-T. Ju
A Novel Role of IL-2 in Organ-Specific Autoimmune Inflammation beyond Regulatory T Cell Checkpoint: Both IL-2 Knockout and Fas Mutation Prolong Lifespan of Scurfy Mice but by Different Mechanisms
J. Immunol., December 15, 2007; 179(12): 8035 - 8041.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Sun, S. Lee, S. Karray, M. Levi-Strauss, K. T. Ames, and P. J. Fink
Cutting Edge: Two Distinct Motifs within the Fas Ligand Tail Regulate Fas Ligand-Mediated Costimulation
J. Immunol., November 1, 2007; 179(9): 5639 - 5643.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Sun, K. T. Ames, I. Suzuki, and P. J. Fink
The Cytoplasmic Domain of Fas Ligand Costimulates TCR Signals
J. Immunol., August 1, 2006; 177(3): 1481 - 1491.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.